Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06945042 · ClinicalTrials.gov registry record · NA

ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia

A NA study of Acute Myeloid Leukemia, sponsored by Wake Forest University Health Sciences.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
2
Study locations

NCT06945042 is a NA study of Acute Myeloid Leukemia that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 120 participants, roughly in line with the 115-participant average among 306 other Acute Myeloid Leukemia trials with a reported enrollment target. The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06945042, a NA study of Acute Myeloid Leukemia, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this research is to see how personal financial burden (financial toxicity) related to cancer affects the overall health and quality of life by evaluating the impact of systematic financial navigation in addition to standard financial distress interventions during cancer treatment.

Conditions Studied

Acute Myeloid Leukemia

Interventions

  • OTHER Arm A
  • OTHER Arm B

Study Locations (2)

North Carolina

  • Levine Cancer Insitute - Charlotte
  • Atrium Health Wake Forest Baptist Comprehensive Cancer Center - Winston-Salem

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2025-06-27
Est. Completion 2028-05
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06945042

The ClinicalTrials.gov registry entry for NCT06945042 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 115-participant average among 306 other Acute Myeloid Leukemia trials with a reported enrollment target. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acute Myeloid Leukemia appearing as the primary indexed condition, and to 2 interventions - of which Arm A is the first listed.

NCT06945042 reports 2 study locations spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT06945042 about?

NCT06945042 is a clinical study titled "ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia". The purpose of this research is to see how personal financial burden (financial toxicity) related to cancer affects the overall health and quality of life by evaluating the impact of systematic financial navigation in addition to standard financial distress interventions during cancer treatment.

What is the current status of trial NCT06945042?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-06-27. Estimated completion is 2028-05.

What conditions does trial NCT06945042 study?

This clinical trial studies the following conditions: Acute Myeloid Leukemia.

What interventions are being tested in trial NCT06945042?

The interventions under investigation include: Arm A (OTHER), Arm B (OTHER).

Who is sponsoring clinical trial NCT06945042?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06945042 being conducted?

This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Acute Myeloid Leukemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Acute Myeloid Leukemia

All registered trials for this condition

North Carolina

All trials with a study site in North Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.